FDA Inspection 1052793 — PaxVax, Inc.
The FDA completed an inspection of PaxVax, Inc. on May 16, 2018 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 16, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- San Diego, CA (United States)